Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06361095 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Confirmatory Efficacy Trial of Attention Bias Modification for Depression

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Mar 1, 2028 to Nov 30, 2027
    • Study completion date: Mar 1, 2028 to May 1, 2028
    • Site details revised
    v3
  2. Minor Interventions: Gamified Attention Bias Modification (Behavioral), Sham Attention Bias Modifcation (Behavioral), Traditional Attention Bias Modification… to Gamified Attention Bias Modification (Behavioral), Sham Attention Bias Modification (Behavioral), Traditional Attention Bias Modification…
    • Eligibility criteria revised
    • Site contact updated
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to compare the efficacy of two related, but different ABM (Attention Biased Modification) treatments for depression in adults with elevated symptoms of depression. The main aims are: * Aim 1:examine whether gamified ABM leads to greater change in the primary and secondary outcomes than sham ABM * Aim 1: establish that gamified ABM is at least as effective as traditional ABM. * Aim 2: identify moderators of ABM efficacy and mechanisms responsible for its efficacy. * Aim 3: Identify the durability of ABM on depression symptoms during short-term follow-up Participants will complete self-report questionnaires, complete eye-tracking tasks, and be clinically assessed through interviews by clinician researchers. If there is a comparison group: Researchers will compare sham, traditional, and gamified treatment groups to see if they moderate symptoms of depression.
Trial Details
NCT Number NCT06361095
Lead Sponsor University of Texas at Austin
Collaborators: Arcade Therapeutics
Conditions
(from sponsor)
Depression
Related terms Depression
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov